SCHEMBL120111

SCHEMBL120111

Cc1c[c]ccn1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL73118 0.72
SCHEMBL1450328 0.71 KDM4E (0.36)
SCHEMBL27612276 0.70
SCHEMBL2888279 0.67
SCHEMBL27042 0.67
SCHEMBL739945 0.67
SCHEMBL358262 0.67
SCHEMBL1063869 0.67
SCHEMBL2186562 0.67
SCHEMBL2165882 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 2384 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12024518-B1 Pyrazolo[4,3-C][1,6]naphthyridines as CK2 inhibitors King Faisal University (SA) 2024-07-02 US claimed
US-12018026-B1 Pyrido[4,3-e][1,2,3]triazolo[1,5-a]pyrimidine as CK2 inhibitors King Faisal University (SA) 2024-06-25 US claimed
US-12018028-B1 5-substituted aminopyrazino[2′,1′:2,3]imidazo[4,5-c][2,7]naphthyridine compounds as CK2 inhibitors King Faisal University (SA) 2024-06-25 US claimed
US-12012406-B1 Pyrido[4,3-e]pyrrolo[1,2-a]pyrimidine as CK2 inhibitors King Faisal University (SA) 2024-06-18 US claimed
US-12012414-B1 Imidazo[1,5-a]pyrido[4,3-e]pyrimidines as CK2 inhibitors King Faisal University (SA) 2024-06-18 US claimed
US-12012407-B1 Pyrazolo[1,5-a]pyrido[4,3-e]pyrimidine-3-carboxylic acids as CK2 inhibitors King Faisal University (SA) 2024-06-18 US claimed
CN-115135656-B Furanoindazole derivatives 拜耳公司 2024-06-14 CN claimed
US-12006317-B1 5-substituted aminopyrimido [6′,1′:2,3] imidazo [4,5-c] [2,6] naphthyridine compounds as CK2 inhibitors King Faisal University (SA) 2024-06-11 US claimed
US-11999736-B1 Pyrazino[2′,1′:2,3]imidazo[4,5-b][1,7]naphthyridines compounds as CK2 inhibitors King Faisal University (SA) 2024-06-04 US claimed
US-11999735-B1 5-substituted aminopyrimido [6′,1′:2,3] imidazo [4,5-c] [2,6] naphthyridine compounds as CK2 inhibitors King Faisal University (SA) 2024-06-04 US claimed
CN-87108111-A Novel imidazole derivative and preparation method thereof 1988-09-28 CN claimed
EP-0270091-A1 Imidazole derivatives, processes for the preparation of the same, pharmaceutical compositions comprising the same, the use of the same for the manufacture of medicaments of therapeutic value, and intermediates formed during said processes TANABE SEIYAKU CO., LTD. (JP) 1988-06-08 EP claimed
EP-0244115-A2 Phenyl-piperazine anti-arrhythmia agents Pfizer Limited (GB) 1987-11-04 EP claimed
CN-87102873-A Phenylpiperazine anti-dysrhythmia agents and preparation method thereof 1987-10-28 CN claimed
EP-0233051-A2 Antiarrhythmic Agents Pfizer Limited (GB) 1987-08-19 EP claimed
US-4497814-A 2-(Pyridinyl)-1,2,4-triazolo[1,5-a]pyrimidines and derivatives useful in increasing cardiac contractility SCHERING CORPORATION (US) 1985-02-05 US claimed
US-4127583-A Preparation of 3-(pyridinyl)-2-cyclohexene-1-ones STERLING DRUG INC. (US) 1978-11-28 US claimed
US-4111946-A Preparation of 3-(pyridinyl)-2-cyclohexen-1-ones STERLING DRUG INC. (US) 1978-09-05 US claimed
US-4075217-A Conversion of 3-(pyridinyl)-2-cyclohexen-1-one to 3-(pyridinyl)anilines STERLING DRUG INC. (US) 1978-02-21 US claimed
US-3957758-A ANTIBIOTICS HOFFMANN-LA ROCHE INC. (US) 1976-05-18 US claimed